Immediate Impact
3 from Science/Nature 58 standout
Citing Papers
The Art and Science of Molecular Docking
2024 Standout
The neuropathobiology of multiple sclerosis
2024 Standout
Works of Robert Guttendorf being referenced
A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Guttendorf | 135 | 32 | 82 | 51 | 25 | 339 | |
| Hidekuni Takahagi | 149 | 45 | 85 | 91 | 26 | 398 | |
| F. Rubio | 78 | 38 | 84 | 89 | 15 | 353 | |
| Toshio Suwa | 115 | 61 | 107 | 33 | 42 | 375 | |
| Duane B. Lakings | 184 | 65 | 50 | 76 | 32 | 367 | |
| P. Muth | 68 | 52 | 194 | 30 | 13 | 341 | |
| John Whitlam | 110 | 57 | 82 | 63 | 17 | 380 | |
| Irving Weliky | 86 | 30 | 46 | 44 | 21 | 357 | |
| Víctor Mangas‐Sanjuán | 97 | 51 | 48 | 19 | 43 | 396 | |
| M. Van Den Ende | 67 | 69 | 33 | 27 | 27 | 327 | |
| Bruno Baune | 59 | 72 | 43 | 44 | 14 | 366 |
All Works
Loading papers...